Ciprofloxacin in dextrose 5% side effects by duration, gender and age - a phase IV clinical study of FDA data

< 1 month:

1. Abdominal pain
2. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
3. Infusion site erythema (reddening of the skin at infusion site)
4. Liver disorder (liver diseases)

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

1. Infusion site reaction
2. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
3. Catatonia (unresponsive to external stimuli)
4. Phlebitis (inflammation of the walls of a vein)
5. Pruritus (severe itching of the skin)

female:

1. Catatonia (unresponsive to external stimuli)
2. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
3. Infusion site erythema (reddening of the skin at infusion site)
4. Liver disorder (liver diseases)

male:

1. Infusion site reaction
2. Abdominal pain
3. Phlebitis (inflammation of the walls of a vein)
4. Pruritus (severe itching of the skin)

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

1. Abdominal pain

30-39:

n/a

40-49:

1. Liver disorder (liver diseases)

50-59:

n/a

60+:

1. Infusion site reaction
2. Catatonia (unresponsive to external stimuli)
3. Phlebitis (inflammation of the walls of a vein)